Laser and LED-based photobiomodulation (PBM) is increasingly used for conditions where the treatment target sits close to, or directly over, the orbit: trigeminal neuralgia, sinusitis, temporomandibular disorders, Bell’s palsy, migraine, and facial acupuncture points. A separate and growing clinical application deliberately irradiates the closed eyelid itself, for dry eye disease and, more recently, investigational work in age-related macular degeneration. These two situations carry very different risk profiles, and conflating them is a common source of confusion in clinics that use Class 3B and Class 4 devices. This article works through the engineering and regulatory basics that apply to any therapeutic laser used near the face, reviews what the injury literature actually shows, and separates the two scenarios so the risk management is proportionate rather than either careless or excessive.
Under IEC 60825-1, the international product-safety standard for laser classification, most therapeutic laser units fall into Class 3B (up to 500 mW) or Class 4 (above 500 mW). Class 3B devices are capable of producing an eye injury from direct intrabeam viewing but are not generally a fire or diffuse-reflection skin hazard; Class 4 devices carry both direct and diffuse-reflection ocular hazard plus skin and fire risk. This classification is fixed by the manufacturer and printed on the device label — it is not something a practitioner can reclassify by using lower settings, since the class reflects the maximum accessible emission the device is capable of, not the parameters selected for a given treatment.
ANSI Z136.3, the American National Standard for the Safe Use of Lasers in Health Care, and its 2024 revision extend explicitly to medical, dental, and therapy offices using Class 3B/4 devices, not only surgical suites. The equivalent EU regulatory framework sits under the Medical Devices Regulation plus workplace optical radiation directives, but the underlying hazard-control logic — controlled area, trained operator, protective eyewear, signage — is the same one ANSI Z136.3 codifies. A practical implication for a solo practitioner clinic: designating a laser safety officer, keeping an eyewear inventory matched to each device’s wavelength, and maintaining a treatment log are standard-of-care expectations for Class 3B/4 use, not surgical-department-only requirements.
Nominal ocular hazard distance (NOHD) is the distance along the beam axis beyond which the irradiance or radiant exposure falls below the applicable maximum permissible exposure. For low-divergence Class 3B laser sources, published NOHD figures for visible-beam units in this power range have been described in the range of roughly 100 to 300 or more meters depending on beam divergence and power — figures calculated for pointer-type sources rather than clinical handpieces, which typically have more divergent beams and correspondingly shorter NOHD, but the underlying calculation is standard and manufacturers are required to supply it. This matters clinically less for room-scale hazard planning in a typical treatment room (where the beam is rarely allowed to propagate unobstructed for meters) and more as the basis for how eyewear optical density (OD) is specified: eyewear OD is chosen so that transmitted irradiance at the operating wavelength and power stays below the maximum permissible exposure, and OD is logarithmic — OD 3 attenuates by a factor of 1,000, OD 5 by a factor of 100,000. A commonly cited rule of thumb is that OD 5 or higher is sufficient for most therapeutic wavelengths and powers in the 3B/4 range, but this is a generalization rather than a substitute for checking the manufacturer’s eyewear specification against the device’s actual wavelength and maximum power. Sunglasses, tinted safety glasses without a laser rating, and general safety goggles provide no verified attenuation and should never be substituted. Eyewear must be wavelength-matched: OD ratings are wavelength-specific, and a pair rated for 810 nm diode emission gives no protection against a 980 nm or 1064 nm source.
Direct evidence on ocular injury from therapeutic PBM/LLLT devices used at typical clinical parameters is very limited — a search of the literature did not return case reports of retinal injury from low-level laser therapy or laser acupuncture devices used within manufacturer parameters. This absence is itself informative but should not be read as proof of zero risk; it more likely reflects both a genuinely lower hazard at typical 3B power/exposure combinations when eyewear is used, and under-reporting.
The clearest evidence base on laser-induced ocular injury near the face comes from the aesthetic and dermatologic laser literature, which uses devices in an overlapping wavelength range (diode 800–983 nm, alexandrite 755 nm, Nd:YAG 1064 nm) to therapeutic PBM units, even though the intended application (hair removal, skin resurfacing) and typical fluence differ substantially from PBM dosing. A published review of eye injuries associated with dermatologic laser treatment found that ocular protection was absent, or was used but removed during treatment of areas close to the eye, in a majority of reported injury cases, and that even correctly used shields and goggles failed in a meaningful minority of cases — attributed to factors including inadequate cooling between pulses, shield overheating during extended sessions, and Bell’s phenomenon, the upward rolling of the globe on eyelid closure that can expose the iris or sclera to a beam intended to pass over closed lids. Longer wavelengths were disproportionately implicated in severe outcomes (retinal and vitreous hemorrhage, preretinal membrane formation, macular hole) because they penetrate deeper and are weakly visible, so an operator or patient may not perceive an off-target exposure as it happens. This literature should be read as a mechanism-relevant analogy rather than direct evidence about PBM devices: it establishes that periorbital treatment with wavelengths PBM practitioners also use carries a real, documented injury mechanism when protection is absent, inconsistent, or defeated by patient movement — a genuinely useful clinical caution even though the fluence and intent of aesthetic laser use differ from PBM.
Separately, a concise review of laser acupuncture in the peer-reviewed literature states plainly that because the lasers used are Class 3B, irradiation could potentially cause serious eye damage, and that both patient and provider must wear protective eyewear during treatment — alongside other site-specific contraindications (avoiding direct irradiation of the eyes, gonads, a pregnant uterus, and known tumors, and caution around the cardiac region and pediatric growth plates). This is consistent, established guidance rather than an isolated opinion, but it is presented in that source as a safety principle rather than backed by its own injury case series.
Photobiomodulation delivered directly to the closed eyelid is an established and separately validated clinical application, most developed for dry eye disease and under active clinical investigation for dry age-related macular degeneration. Randomized controlled trials of closed-eyelid PBM for dry eye have reported improvement in tear film parameters and symptom scores with treatment described as well tolerated, and early-phase safety and tolerability data for PBM in dry AMD have likewise not identified significant ocular safety signals in the populations studied to date. It is important to be precise about what makes this different from an incidental periorbital exposure: these protocols use devices specifically designed, wavelength-selected, and dosed for transpalpebral delivery, applied under controlled parameters as part of a validated protocol, typically by or under supervision of eye-care specialists, at fluences chosen for that specific application. This is not equivalent to, and does not license, directing a general-purpose 3B/4 PBM handpiece at closed eyelids using parameters set for a musculoskeletal or dermatologic target. The evidence supporting deliberate closed-eyelid PBM should be regarded as an established but application-specific finding, not a general reassurance that any closed-eyelid exposure from any therapeutic laser is safe.
When treating trigeminal, sinus, TMJ, or facial acupuncture points near the orbit, the patient’s eyes should be protected with wavelength-matched, OD-rated eyewear, not just closed — closure alone does not reliably prevent exposure given Bell’s phenomenon and the possibility of transmission through thin eyelid tissue at higher powers. The operator should also wear rated eyewear for the duration of beam-on time, including during test fires. Handpiece angle should be controlled so the beam axis does not traverse toward the orbit even incidentally, and this is particularly relevant with more divergent, higher-power Class 4 units where diffuse reflection off skin or metal instruments (a consideration also raised in laser acupuncture guidance where needles may be present in the field) adds a secondary hazard pathway beyond the direct beam.
A frequent practical error is treating eyewear as interchangeable across devices in a multi-laser clinic. Eyewear should be labeled and stored per device, matched explicitly to that unit’s wavelength and maximum output, and checked periodically for scratches or coating degradation that reduce rated attenuation.
Ocular risk from therapeutic Class 3B and Class 4 lasers used near the face is governed by the same classification and hazard-distance principles that apply to any laser product, and the strongest injury evidence comes from the aesthetic laser literature using overlapping wavelengths rather than from PBM-specific case series, a gap that should be read as limited data rather than confirmed safety. Deliberate closed-eyelid PBM for dry eye and investigational AMD applications is a distinct, separately evidenced practice using purpose-designed protocols and should not be extrapolated to justify incidental periorbital exposure from general-purpose devices. Wavelength-matched, OD-rated eyewear for both patient and operator, careful handpiece control near the orbit, and treating eyelid closure as an adjunct rather than a substitute for eyewear remain the practical core of safe practice in this treatment area.
📧 in**@*****************re.com
☎️ +351 915 698 420
Academia OLA Laser
Instrutor: Oren Ziv Ram
NIF: 314055314
Formação online em acupuntura laser e auriculomedicina
© 2025 OLA Laser Academy. Todos os direitos reservados.